<DOC>
	<DOCNO>NCT01984684</DOCNO>
	<brief_summary>The purpose study evaluate effect Delafloxacin versus Vancomycin plus Aztreonam treatment patient acute bacterial skin soft tissue infection .</brief_summary>
	<brief_title>Delafloxacin v Vancomycin Aztreonam Treatment Acute Bacterial Skin Skin Structure Infections</brief_title>
	<detailed_description>The purpose study determine delafloxacin , investigational drug , safe effective treatment skin nearby tissue infection compare combination antibiotic , vancomycin aztreonam .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Soft Tissue Infections</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Aztreonam</mesh_term>
	<criteria>Adult ( ≥ 18 year age ) men woman diagnosis ABSSSI ( cellulitis/erysipelas , wound infection , major cutaneous abscess , burn infection ) least two sign systemic infection In opinion investigator , subject must require suitable candidate IV antibiotic therapy , subject must able willing comply protocol requirement A medical history significant hypersensitivity allergic reaction quinolones , betalactams , vancomycin , vancomycin derivative accord judgment investigator . Women pregnant lactating . Any chronic underlying skin condition site infection may complicate assessment response , include infection involve prosthetic joint , human animal bite , osteomyelitis , decubitus ulcer , diabetic foot ulcer , septic arthritis , mediastinitis , necrotizing fasciitis , anaerobic cellulitis , synergistic necrotizing cellulitis , myositis , tendinitis , endocarditis , sustain shock , gangrene gas gangrene ; burn cover ≥10 % body surface area ; severely compromise immune system , severely impaired arterial blood supply extremity ABSSSI , deep vein thrombosis superficial thrombophlebitis , require either amputation multiple debridement procedure . Any underlying disease , opinion investigator , could interfere subject 's ability participate study include severe cardiac disease , know history liver disease , endstage renal disease , malignancy , psychiatric disorder , ongoing treatment seizure untreated history seizure , life expectancy &lt; 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Bacterial skin infection</keyword>
	<keyword>infection</keyword>
	<keyword>skin</keyword>
	<keyword>delafloxacin</keyword>
	<keyword>vancomycin</keyword>
	<keyword>aztreonam</keyword>
	<keyword>MRSA bacteria</keyword>
	<keyword>bacterial infection</keyword>
	<keyword>Anti-Infective Agents</keyword>
</DOC>